Shashank Tripathi

slide-2

slide-1

slide-3

slide-4

slide-5

slide-6

slide-7

slide-9

Welcome to lab webpage of Dr. Shashank Tripathi in CIDR, IISc

Dr Shashank Tripathi
Assistant Professor
Wellcome Trust India Alliance Intermediate Fellow
Microbiology & Cell Biology Department,
Centre for Infectious Disease Research,
Indian Institute of Science,
CV Raman Avenue, Bangalore-560012, India
Phone: +91 8022932884
mail: shashankt@iisc.ac.in

News Updates

Rohan Gets a travel award and the invitation to deliver a research talk at the 'Pandemic Preparedness' conference in ICGEB Trieste (Link)
Oyahida goes to present a research poster at the Keystone Positive Strand RNA Virus Meeting in Killarney, Ireland. (Link)
Shashank delivers a research talk at Immunocon 2024 at IISc, Bengaluru. (Link)
Oyahida gets SERB Internationa Travel Award to attend Keystone Positive Strand RNA Virus Meeting in Killarney, Ireland. (Link)
Shashank gets the Axis Bank International Travel Award to attend the Options XI meeting in Brisbane, Australia. (Link)
Shashank gets invited to chair a session and present research at the Options XI meeting in Brisbane, Australia. (Link)
Shashank goes to Sumit Chanda's lab at Scripps Research, San Diego, USA, for a 3-month research Visit. (Link)
Mansi gets a travel award and invitation to deliver a talk and present a poster at ASV 2024 in Columbus, Ohio, USA. (Link)

Featured in Deccan Herald (23rd February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by Deccan Herald under the title “IISc scientists find a compound in mammals that can restrict coronavirus”
Featured in Jansatta(22nd February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by Jansatta
Featured in NewsMedical.net (21st February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by NewsMedical.net
Abhijith and Oyahida’s Research article published in EBioMedicine(The Lancet)-Abhijith,Oyahida,et al(12th August 2021)
Featured in Telegraph (19th February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by Telegraph titled “Covid: Hope of anti-viral shield against multiple viruses”
Quoted by Down To Earth (21st December 2021) – Shashank Tripathi got quoted in Down To Earth article titled ‘COVID-19 immunity: Treading turbulent waters’
Official Press Release by IISc (14th November 2021) – IISc release an official Press Release on our published work on identification of COVID-19 severity marker
Highlighted on KERNEL Research News IISc (14th November 2021) – “Leads for COVID-19 Prognosis and Therapy from Nasal Swabs got highlighted on KERNEL Research news IISc.
Publication in Critical Reviews in Immunology(October 2021) – A review article titled “Innate Immune subversion strategies of Human Flaviviruses” authored by Sumandeep Kaur and Shashank Tripathi got published in the journal Critical Reviews in Immunology
Publication in Nature Microbiology (23rd September 2021) – A research article co authored by Dr Shashank Tripathi on a mechanism for evasion of autophagy got published in Nature Microbiology titled “Restriction Factor compendium for Influenza A virus reveals a mechanism for evasion of autophagy”.
Featured in Hindustan Times(29th August 2021) – Our published work on the identification of COVID-19 severity marker got featured in the India News section of Hindustan times titled, “IISc researchers identify marker to determine Covid severity”
Featured in Deccan Herald(24th August 2021) – Our peer-reviewed work of identifying a novel marker for the prediction of Covid-19 severity, merely through RT PCR test got featured in Deccan Herald titled, “RT-PCR can predict Covid severity: IISc study”
Join Lab For Masters Thesis(7th may 2021) - Swarnima (BHU) and Manish (Amity, Noida) join lab for Masters thesis
Featured by India Alliance(20th August 2021) Our published work on the identification of COVID-19 severity marker got covered by India Alliance
Top 5 in BRICS Young Scientist Conclave 2021 – Rajesh got selected in the top 5 for BRICS Young Scientist Conclave 2021
Featured in Jansatta (13th August 2021) – Our published work on the identification of COVID-19 severity marker got featured in Jansatta
Publication in Lancet EBioMedicine (12th August 2021) – Abhijith and Oyahida’s Research article on the identification of COVID-19 severity marker got published in EBioMedicine(The Lancet)
Publication in ACE Infectious Disease(14th July 2021) – Research article co-authored by Dr Shashank Tripathi got published in ACE Infectious Disease-Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative
Official Press Release By IISc (1st July 2021) – IISc released an official press release on COVID-19 Vaccine Testing Center titled “Viral BSL-3 facility and DBT-BIRAC COVID-19 Vaccine Testing Centre at IISc”
Featured in The Indian Express (1st July 2021) – COVID-19 vaccine testing centre got covered in The Indian Express under the title “Karnataka: IISc’s Covid vaccine testing facility in Bengaluru first to be supported by BIRAC in south India”
Featured in Deccan Herald (29th June 2021) – COVID-19 vaccine testing centre got covered in Deccan Herald under the title Vaccine testing centre started at BSL-3 lab at Bengaluru’s IISc
Featured in The Hindu (26th June 2021) – COVID-19 vaccine testing centre got covered in The Hindu under the title “COVID-19 vaccine testing centre set up at IISc”
Interviewed by Rediff (31st March 2021) – Shashank Tripathi got interviewed by Rediff published under the title ‘One must be cautious, not scared, of the new variants’
Public outreach publication in The Times of India(4th March 2021) – Abhijith and Dr Shashank Tripathi published an article in Times of India Article Titled “Lessons from a century-old pandemic for current India”
New Lab Members (22nd February 2021) – Rishad Shiraz joins the lab as a PhD student

“We are trying to understand how viruses make us sick, and are interested in developing means to prevent that”.

Our group studies virus-host interactions of emerging human RNA viruses including Influenza, SARS-CoV-2, and Flaviviruses. We strive to translate this knowledge for the development of broad-spectrum antivirals and vaccines. Our expertise is in the multi-omics analysis of virus-host interactions, viral reverse genetics, and small animal models of viral pathogenesis.